Recent Finacing
Recent Raise
Precision BioSciences develops genome‑editing therapies and agricultural products using its proprietary ARCUS homing‑endonuclease platform, pursuing allogeneic CAR‑T, in vivo gene correction, and genome‑edited food programs.
